Trends in Short- and Long-Term ST-Segment-Elevation Myocardial Infarction Prognosis Over 3 Decades: A Mediterranean Population-Based ST-Segment-Elevation Myocardial Infarction Registry.
Angina Pectoris
/ epidemiology
Cardiovascular Agents
/ therapeutic use
Coronary Artery Disease
/ epidemiology
Female
Hospital Mortality
/ trends
Humans
Long Term Adverse Effects
/ etiology
Male
Middle Aged
Percutaneous Coronary Intervention
/ methods
Prognosis
Proportional Hazards Models
Registries
/ statistics & numerical data
ST Elevation Myocardial Infarction
/ complications
Spain
/ epidemiology
Ventricular Dysfunction, Right
/ epidemiology
Ventricular Fibrillation
/ etiology
STEMI complications
STEMI mortality
ST‐segment–elevation myocardial infarction
prognosis
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
20 10 2020
20 10 2020
Historique:
pubmed:
16
10
2020
medline:
16
3
2021
entrez:
15
10
2020
Statut:
ppublish
Résumé
Background Coronary artery disease remains a major cause of death despite better outcomes of ST-segment-elevation myocardial infarction (STEMI). We aimed to analyze data from the Ruti-STEMI registry of in-hospital, 28-day, and 1-year events in patients with STEMI over the past 3 decades in Catalonia, Spain, to assess trends in STEMI prognosis. Methods and Results Between February 1989 and December 2017, a total of 7589 patients with STEMI were admitted consecutively. Patients were grouped into 5 periods: 1989 to 1994 (period 1), 1995 to 1999 (period 2), 2000 to 2004 (period 3), 2005 to 2009 (period 4), and 2010 to 2017 (period 5). We used Cox regression to compare 28-day and 1-year STEMI mortality and in-hospital complication trends across these periods. Mean patient age was 61.6±12.6 years, and 79.3% were men. The 28-day all-cause mortality declined from period 1 to period 5 (10.4% versus 6.0%;
Identifiants
pubmed: 33054490
doi: 10.1161/JAHA.120.017159
pmc: PMC7763375
doi:
Substances chimiques
Cardiovascular Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e017159Investigateurs
Maria José Martínez-Membrive
(MJ)
Elisabeth Zamora
(E)
Angel Caballero
(A)
Cinta Llibre
(C)
Oriol Rodríguez-Leor
(O)
Eduard Fernandez-Nofrerias
(E)
Omar Abdul-Jawad
(O)
Victoria Vilalta
(V)
Références
Am J Cardiol. 2016 Apr 15;117(8):1213-8
pubmed: 26874548
Int J Cardiol. 2015 Apr 15;185:256-62
pubmed: 25814213
Lancet. 2014 Apr 12;383(9925):1305-1312
pubmed: 24461715
Am Heart J. 2000 Jun;139(6):1014-21
pubmed: 10827382
Eur Heart J. 2012 Oct;33(20):2569-619
pubmed: 22922416
J Am Heart Assoc. 2020 Oct 20;9(20):e017159
pubmed: 33054490
Circulation. 1999 Apr 6;99(13):1767-73
pubmed: 10190889
Eur Heart J. 2012 Dec;33(23):2888-91
pubmed: 23202667
Eur Heart J. 2015 Apr 21;36(16):976-83
pubmed: 25205530
Am J Cardiol. 2018 Jul 15;122(2):185-191
pubmed: 29751953
N Engl J Med. 2007 Jun 7;356(23):2388-98
pubmed: 17554120
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):117-25
pubmed: 26884615
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
ESC Heart Fail. 2018 Feb;5(1):101-105
pubmed: 29285897
JAMA. 2012 Sep 12;308(10):998-1006
pubmed: 22928184
Eur Heart J. 2003 Jan;24(1):28-66
pubmed: 12559937
Circulation. 2012 Apr 17;125(15):1848-57
pubmed: 22420957
J Am Coll Cardiol. 2018 Aug 28;72(9):959-966
pubmed: 30139440
Eur Heart J. 2016 Apr 1;37(13):1034-40
pubmed: 26586783
N Engl J Med. 2010 Jun 10;362(23):2155-65
pubmed: 20558366
Eur Heart J. 2006 Oct;27(19):2285-93
pubmed: 16908490
Am J Cardiol. 2018 Aug 15;122(4):529-536
pubmed: 29960663
JAMA. 1983 Oct 7;250(13):1757-65
pubmed: 6350634
Circulation. 2009 Mar 10;119(9):1211-9
pubmed: 19237658
J Am Coll Cardiol. 1999 May;33(6):1533-9
pubmed: 10334419
Circulation. 1990 Aug;82(2):664-707
pubmed: 2197021
Am Heart J. 2011 Sep;162(3):444-50
pubmed: 21884859
PLoS One. 2019 Feb 22;14(2):e0209502
pubmed: 30794547
Am J Cardiol. 2019 Jan 15;123(2):206-211
pubmed: 30409411